Epithalon (Epitalon)

Epithalon (also spelled Epitalon) is a synthetic tetrapeptide based on the naturally occurring peptide Epithalamin, which was isolated from the pineal gland. Developed by the St. Petersburg Institute of Bioregulation and Gerontology under the leadership of Dr. Vladimir Khavinson, it is part of a class of compounds called "bioregulatory peptides" that are proposed to have tissue-specific effects. The primary research focus on Epithalon has been its potential effects on telomerase activity and cellular aging. Telomeres are protective caps on chromosome ends that shorten with each cell division, and telomerase is the enzyme that can rebuild them.

Epithalon's proposed mechanisms involve telomerase and pineal function: **Telomerase Activation:** Research suggests Epithalon may stimulate telomerase activity, the enzyme that extends telomeres. Telomere shortening is associated with cellular senescence, and telomerase activation could theoretically extend replicative capacity of cells. **Pineal Gland Function:** As a synthetic analog of pineal peptides, Epithalon may influence pineal gland function, including melatonin production. The pineal gland plays important roles in circadian rhythm regulation and has been implicated in aging processes. **Gene Expression Effects:** Studies in cell culture and animal models suggest Epithalon affects expression of genes related to cell cycle regulation, DNA repair, and oxidative stress response. **Antioxidant Activity:** Some research indicates Epithalon may have antioxidant properties, potentially reducing oxidative damage to DNA and cellular structures.